Gene Therapy – Target Factor Level and Other Considerations

Gene Therapy - it's types, applications and future.Подробнее

Internal Medicine Grand Rounds: New Goals and Therapeutic Options for Type 2 DiabetesПодробнее

New Goals and Therapeutic Options for Type 2 Diabetes MellitusПодробнее

Gene Therapy for FVIIIПодробнее

Considerations on Regulation of Gene Therapy for HemophiliaПодробнее

Setting Safety Parameters in Gene Therapy Trials with Thomas Wechsler – The IssueПодробнее

Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence - AMПодробнее

Liver-Directed Gene Therapy for Hemophilia with Immune Shielded Lentiviral VectorsПодробнее

Gene Therapy for Haemophilia: What, Why, How, When, Who, and Where?Подробнее

Gene Therapy: Getting Up to SpeedПодробнее

Key Considerations of Gene Therapy Development: A Caregiver's StoryПодробнее

Genetic Therapies for Genetic Diseases: Results and Lessons from Recent SuccessesПодробнее

Gene therapy: Is robust scientific inquiry the missing factor?Подробнее

Follow-up on Gene Therapy (FLT180a) Achieving Normal FIX Activity Levels (B-AMAZE Study)Подробнее

Medicine for members: Gene therapy for haemophiliaПодробнее

Gene Therapy in Hemophilia: Common Concerns in Gene TherapyПодробнее

How can we improve the efficacy and safety of gene therapy?Подробнее

3. Current and Future Gene Therapy in Hemophilia, Prof. John Pasi, London, UkПодробнее

Gene Therapy for the Treatment of Hemophilia B: Andrew M. Davidoff, MD at TEDxSonomaCountyПодробнее

Gene Therapy in HemophiliaПодробнее

Gene Therapy for Genetic Disease: The Long and Winding RoadПодробнее

The Science of Gene Therapy by PfizerПодробнее